What this means
This is a trial plan that has not started enrolling people yet. No results have been posted, so we do not know if the supplement works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 18–80
- Where
- Not listed
The science
- Registered title
- TA-65 and Aging Associated Microvascular Dysfunction
- Trial ID
- NCT05598359 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Telomere Shortening, Aging, Vascular Diseases
- What is tested
- TA-65, Placebo
- Sponsor
- Medical College of Wisconsin
- Ages
- 18 Years to 80 Years
- Dates
- First posted Oct 28, 2022 · updated May 1, 2026
Registry summary
The goal of this clinical trial is to test whether activation of telomerase with a dietary supplement (TA-65) improves microvascular function.